Minimally invasive surgical biopsy confirms PET findings in esophageal cancer

Surg Endosc. 1997 Dec;11(12):1213-5. doi: 10.1007/s004649900572.

Abstract

This report describes our initial experience using positron emission tomography (PET) scanning in esophageal cancer patients. In two patients PET identified distant metastatic disease missed by conventional staging. Laparoscopic biopsy provided histological confirmation of metastases. In the third patient, locoregional lymph nodes were identified by PET and confirmed by surgical staging. In this preliminary report, PET appears to be a promising new noninvasive modality for staging patients with esophageal cancer.

Publication types

  • Case Reports

MeSH terms

  • Adenocarcinoma / diagnostic imaging*
  • Adenocarcinoma / pathology
  • Adenocarcinoma / secondary
  • Aged
  • Biopsy / methods*
  • Esophageal Neoplasms / diagnostic imaging*
  • Esophageal Neoplasms / pathology
  • Fluorodeoxyglucose F18
  • Humans
  • Laparoscopy*
  • Liver Neoplasms / diagnostic imaging
  • Liver Neoplasms / pathology
  • Liver Neoplasms / secondary
  • Lumbar Vertebrae / diagnostic imaging
  • Lumbar Vertebrae / pathology
  • Lymphatic Metastasis / diagnostic imaging
  • Lymphatic Metastasis / pathology
  • Male
  • Middle Aged
  • Minimally Invasive Surgical Procedures
  • Neoplasm Staging
  • Radiopharmaceuticals
  • Sacroiliac Joint / diagnostic imaging
  • Sacroiliac Joint / pathology
  • Spinal Neoplasms / diagnostic imaging
  • Spinal Neoplasms / pathology
  • Spinal Neoplasms / secondary
  • Tomography, Emission-Computed*

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18